Philadelphia chromosome in relapsed childhood acute lymphoblastic leukemia: A matched-pair analysis

Journal of Clinical Oncology

Volumn 15, Issue 6, 1997, Pages 2231-2237

  Beyermann, Birgit ^a   Adams, Hans Peter ^a   Henze, Günter ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CANCER REGRESSION; CHILD; CHROMOSOME 22; CHROMOSOME 9; CHROMOSOME BREAKAGE; CHROMOSOME TRANSLOCATION; CYTODIAGNOSIS; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; RECURRENT DISEASE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR;

EID: 0030900148     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1997.15.6.2231     Document Type: Article

References (33)

1. Nowell PC, Hungerford DA: A minute chromosome in human chronic granulocytic leukemia. Science 132:1497-1500, 1960
2. Rowley JD: Chromosome abnormalities in leukemia. J Clin Oncol 6:194-202, 1988
3. Groffen J, Stephenson JR, Heisterkamp N, et al: Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22. Cell 36:93-99, 1984
4. Lugo TG, Pendergast AM, Muller AJ, et al: Tyrosine kinase activity and transformation potency of bcr-abl oncogene products. Science 247:1079-1082, 1990
5. Kantarjian HM, Talpaz M, Dhingra K, et al: Significance of the p210 versus p190 molecular abnormalities in adults with Philadelphia chromosome-positive acute leukemia. Blood 78:2411-2418, 1991
6. Fainstein E, Marcelle C, Rosner A, et al: A new fused transcript in Philadelphia chromosome positive acute lymphocytic leukaemia. Nature 330:386-388, 1987
7. Clark SS, McLaughlin J, Crist WM, et al: Unique forms of the abl tyrosine kinase distinguish Ph1-positive CML from Ph1-positive ALL. Science 235:85-88, 1987
8. Crist W, Carroll A, Shuster J, et al: Philadelphia chromosome positive childhood acute lymphoblastic leukemia: Clinical and cytogenetic characteristics and treatment outcome. A Pediatric Oncology Group study. Blood 76:489-494, 1990
9. Schlichen S, Borkhardt A, Reinisch I, et al: Incidence and clinical outcome of children with BCR/ABL-positive acute lymphoblastic leukemia (ALL). A prospective RT-PCR study based on 673 patients enrolled in the German pediatric multicenter therapy trials ALL-BFM-90 and CoALL-05-92. Leukemia 10:957-963, 1996
10. Fletcher JA, Lynch EA, Kimball VM, et al: Translocation (9; 22) is associated with extremely poor prognosis in intensively treated children with acute lymphoblastic leukemia. Blood 77:435-439, 1991
11. Beyermann B, Agthe AG, Adams HP, et al: Clinical features and outcome of children with first marrow relapse of acute lymphoblastic leukemia expressing bcr-abl fusion transcripts. Blood 87:1532-1538, 1996
12. Linker CA, Levitt LJ, O'Donnell M, et al: Treatment of adult acute lymphoblastic leukemia with intensive cyclical chemotherapy: A follow-up report. Blood 78:2814-2822, 1991
13. Henze G, Fengler R, Hartmann R, et al: BFM Group treatment results in relapsed childhood acute lymphoblastic leukemia. Haematol Blood Transfus 33:619-626, 1990
14. Henze G, Fengler R, Hartmann R, et al: Six-year experience with a comprehensive approach to the treatment of recurrent childhood acute lymphoblastic leukemia (ALL-REZ BFM 85). A relapse study of the BFM Group. Blood 78:1166-1172, 1991
15. Adams HP, Hartmann R, Fengler R, et al: Ergebnisse der Studien ALL-REZ BFM zur Behandlung von Kindern mit Rezidiv einer akuten lymphatischen Leukämie. Monatsschr Kinderheilkd. Berlin, Germany, Springer, 1995, p 1159
16. Rowley JD: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature 243:290-293, 1973
17. Maurer J, Janssen JW, Thiel E, et al: Detection of chimeric bcr-abl genes in acute lymphoblastic leukaemia by the polymerase chain reaction. Lancet 337:1055-1058, 1991
18. Hartung J: Statistik: Lehr- und Handbuch der angewandten Statistik (ed 10). München, Germany, Oldenbourg Verlag, 1995
19. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
20. Cox DR, Oakes D: Analysis of Survival Data. London, United Kingdom, Chapman & Hall, 1984
21. Kawasaki ES, Clark SS, Coyne MY, et al: Diagnosis of chronic myeloid and acute lymphocytic leukemias by detection of leukemia-specific mRNA sequences amplified in vitro. Proc Natl Acad Sci USA 85:5698-5702, 1988
22. Westbrook CA, Hooberman AL, Spino C, et al: Clinical significance of the BCR-ABL fusion gene in adult acute lymphoblastic leukemia: A Cancer and Leukemia Group B study (8762). Blood 80:2983-2990, 1992
23. Preudhomme C, Fenaux P, Lal JL, et al: Philadelphia negative, BCR-ABL positive adult acute lymphoblastic leukemia (ALL) in 2 of 39 patients with combined cytogenetic and molecular analysis. Leukemia 7:1054-1057, 1993
24. Radich JP, Kopecky KJ, Boldt DH, et al: Detection of bcr-abl fusion genes in adult acute lymphoblastic leukemia by the polymerase chain reaction. Leukemia 8:1688-1695, 1994
25. Bloomfield CD, Peterson LC, Yunis JJ, et al: The Philadelphia chromosome (Ph1) in adults presenting with acute leukaemia: A comparison of Ph1+ and Ph1- patients. Br J Haematol 36:347-358, 1977
26. Priest JR, Robinson LL, McKenna RW, et al: Philadelphia chromosome positive childhood acute lymphoblastic leukemia. Blood 56:15-22, 1980
27. Ribeiro RC, Abromowitch M, Raimondi SC, et al: Clinical and biologic hallmarks of the Philadelphia chromosome in childhood acute lymphoblastic leukemia. Blood 70:948-953, 1987
28. Rubin CM, LeBeau MM, Mick R, et al: Impact of chromosomal translocations on prognosis in childhood acute lymphoblastic leukemia. J Clin Oncol 9:2183-2192, 1991
29. Scherrer R, Bettelheim P, Geissler K, et al: High efficacy of the German multicenter ALL (GMALL) protocol for the treatment of adult acute lymphoblastic leukemia (ALL)-a single-institution study. Ann Hematol 69:181-188, 1994
30. Groffen J, Voncken JW, Kaartinen V, et al: Ph-positive leukemia: A transgenic mouse model. Leuk Lymphoma 11:19-24, 1993 (suppl 1)
31. Campana D, Pui CH: Detection of minimal residual disease in acute leukemia: Methodologie advances and clinical significance. Blood 85:1416-1434, 1995
32. Borkhardt A, Gossen R, Repp R, et al: The bcr/abl rearrangement is associated with an increased mdr gene expression in children with acute lymphoblastic leukemia. Onkologie 18:134, 1995 (suppl 2)
33. van Denderen J, ten Hacken P, Berendes P, et al: Detection of tumor-specific antigens in Philadelphia chromosome positive leukemias. Leuk Lymphoma 11:29-32, 1993 (suppl 1)